References

1. R. Langer, in "Controlled Drug Bioavailability" (V. Smolen, Ed.), Vol 3. Wiley and Sons, New York, 1985.

2. S. M. Moghimi, A. C. Hunter, and J. C. Murray, Pharmacol. Rev. 53, 283 (2001).

4. S. M. Moghimi, C. Porter, S. S. Davis, and L. Illum, Biochem. Biophys. Res. Commun. 177, 861 (1991).

5. L. Illum, S. S. Davis, S. Müller, E. Mak, and P. West, Life Sci. 40, 367 (1987).

6. J. Saphiro, S. Reisner, G. Lichtenberg, and R. Meltzer, J. Am. Coll. Cardiol. 16, 1603 (1990).

7. D. Bazile, C. Ropert, P. Huve, T. Verrecchia, M. Marlard, A. Fry-dman, M. Veillard, and G. Spenlehauer, Biomaterials 13, 1093 (1992).

8. A. Le Ray, M. Vert, J. Gauthier, and J. Benoit, Int. J. Pharm. 106, 201 (1994).

9. R. Gref, Y. Minamitake, M. T. Peracchia, V. Trubetskoy, V. Torchilin, and R. Langer, Science 263, 1600 (1994).

10. J. Kreuter, U. Täuber, and V. Illi, J. Pharm. Sci. 68, 1443 (1979).

11. R. Abra, M. Bosworth, and C. Hunt, Res. Commun. Chem. Pathol. Pharmacol. 29, 349 (1980).

12. R. Profitt, L. Williams, C. Presant, G. Tin, J. Uliana, R. Gamble, and J. Baldeschwieler, Science 220, 502 (1983).

13. J. Scieszka, L. Maggiora, S. Wright, and M. Cho, Pharm. Res. 8, 65 (1991).

14. G. Borchard and J. Kreuter, Pharm. Res. 13, 1055 (1996).

15. L. Fries and M. Franck, in "The Molecular Basis of Blood Diseases" (G. Stamatoyannopoulos, A. Nienhuis, P. Leder, and P. Majerus Eds.), p. 450-485. W. Saunders, Philadelphia, 1987.

16. K. D. Caldwell, in "Targeting of Drugs 6. Strategies for Stealth Therapeutic Systems" (G. Gregoriadis and B. Mc Cormack, Eds.), p. 1-15. Plenum Press, New York, 1998.

17. C. van Oss, M. Woeppel, and S. Marquart, J. Reticuloendothel. Soc. 13, 221 (1973).

18. K. Yamada, Annu. Rev. Biochem. 52, 761 (1983); D. Mosher, Annu. Rev. Med. 35, 561 (1984).

19. F. Ulrich and D. Zilversmit, Am. J. Physiol. 218, 1118 (1970).

20. J. Williamson and E. Rowald, J. Cell Biol. 47, 228a (1970).

21. S. M. Moghimi and H. M. Patel, Biochim. Biophys. Acta 984, 384

22. I. Muir, S. M. Moghimi, L. Illum, S. S. Davis, and M. C. Davies, Biochem. Soc. Trans. 19, 329S (1991).

23. S. M. Moghimi, I. Muir, L. Illum, S. S. Davis, and V. Kolb-Bachofen, Biochim. Biophys. Acta 1179, 157 (1993).

24. D. Elbert and J. Hubbel, Annu. Rev. Mater. Sci. 26, 365 (1996).

25. M. Woodle, in "Poly(ethylene glycol) Chemistry and Biological Applications" (J. Harris and S. Zalipsky, Eds.). ACS Symp. Series, Washington, DC, 1997.

26. S. Jeon, J. Lee, J. Andrade, and P. de Gennes, J. Colloid Interface Sci. 142, 149 (1991).

27. S. Jeon and J. Andrade, J. Colloid Interface Sci. 142, 159 (1991).

28. V. Torchilin and V. Trubetskoy, Adv. Drug Delivery Rev. 16, 141 (1995).

29. V. Torchilin, V. Omelyanenko, M. Papisov, A. Bogdanov, V. Tru-betskoy, J. Herron, and C. Gentry, Biochim. Biophys. Acta 1195, 11 (1994).

31. S. Tröster and J. Kreuter, J. Microencapsul. 9, 19 (1992).

32. L. Illum and S. S. Davis, J. Pharm. Sci. 72, 1086 (1983).

33. L. Araujo, R. Lobenberg, and J. Kreuter, J. Drug Target. 6, 373 (1999).

34. S. E. Dunn, S. Stolnick, M. C. Garnett, M. C. Davies, A. G. Coombes, D. C. Taylor, M. Irving, S. Purkiss, T. F. Tadros, S. S. Davis, and L. Illum, Proc. Intern. Symp. Controll. Release Bioact. Mater., Controlled Release Soc. 21, 210 (1994).

35. K. Petrak, in "Pharmaceutical particulate carriers" (A. Roland Ed.). Marcel Dekker, New York, 1993.

36. J. C. Neal, S. Stolnik, E. Schacht, E. R. Kenawy, M. C. Garnett, S. S. Davis, and L. Illum, J. Pharm. Sci. 87, 1242 (1998).

37. A. Klibanov, K. Maruyama, V. Torchilin, and L. Huang, FEBS Lett. 268, 235 (1990).

38. G. Blume and G. Cevc, Biochim. Biophys. Acta 1029, 91 (1990).

39. K. Kataoka, G. Kwon, M. Yokoyama, T. Okano, and Y. Sakurai, J. Controlled Release 24, 119 (1993).

40. S. E. Dunn, A. Brindley, S. S. Davis, M. C. Davies, and L. Illum, Pharmacol. Res. 11, 1016 (1994).

41. M. Master, A. van Velthoven, W. Norde, and J. Lyklema, Colloids Surf., A 83, 255 (1994).

42. B. Müller and T. Kissel, Pharm. Pharmacol. Lett. 3, 67 (1993).

43. D. Bazile, C. Prud'homme, M. Bassoullet, M. Marlard, G. Spen-lehauer, and M.Veillard, J. Pharm. Sci. 84, 493-498 (1995).

44. M. T. Peracchia, R. Gref, Y. Minamitake, A. Domb, N. Lotan, and R. Langer, J. Controlled Release 46, 223 (1997).

45. M. T. Peracchia, D. Desmaele, P. Couvreur, and J. D'Angelo, Macromolecules 30, 846 (1997).

46. R. Perret and A. Skoulios, Makromol. Chem. 156, 143 (1972).

47. K. Zhu, L. Xiangzhou, and Y. Shilin, J. Appl. Polym. Sci. 39, 1

48. A. Domb, R. Gref, Y. Minamitake, M. T. Peracchia, and R. Langer, U.S. Patent 6,007,845, 1999.

49. M. T. Peracchia, S. Harnisch, H. Pinto-Alphandary, A. Gulik, J. Dedieu, D. Desmaele, J. d'Angelo, R. H. Muller, and P. Couvreur, Biomaterials 20, 1269 (1999).

50. G. Harper, S. S. Davis, M. C. Davies, M. Norman, T. F. Tadros, D. C. Taylor, M. P. Irving, J. Waters, and J. Watts, Biomaterials 16, 427 (1995).

51. T. Cosgrove, P. Griffiths, and P. Lloyd, Langmuir 11, 1457 (1995).

52. J. Hrkach, M. T. Peracchia, A. Domb, N. Lotan, and R. Langer, Biomaterials 18, 27 (1997).

53. T. Armstrong, M. Davies, and L. Illum, J. Drug Target. 4, 389 (1997).

54. P. Quellec, R. Gref, L. Perrin, E. Dellacherie, F. Sommer, J. M. Verbavatz, and M. Alonso, J. Biomed. Mater. Res. 42, 45 (1998).

55. S. Stolnik, S. E. Dunn, M. C. Garnett, M. C. Davies, A. G. A. Coombes, D. C. Taylor, M. P. Irving, S. C. Purkiss, T. F. Tadros, S. S. Davis, and L. Illum, Pharm. Res. 11, 1800 (1994).

56. M. Vittaz, D. Bazile, G. Spenlehauer, T. Verrecchia, M. Veillard,

F. Puisieux, and D. Labarre, Biomaterials 17, 1575 (1996).

57. H. Sahli, J. Tapon-Bretaudiere, A. Fischer, C. Sternberg, G. Spen-lehauer, T. Verrecchia, and D. Labarre, Biomaterials 18, 281 (1997).

58. M. F. Zambaux, F. Bonneaux, R. Gref, E. Dellacherie, and

C. Vigneron, J. Biomed. Mater. Res. 44, 109 (1999).

59. M. T. Peracchia, C. Vauthier, C. Passirani, P. Couvreur, and

60. T. Blunk, D. F. Hochstrasser, J. C. Sanchez, B. W. Müller, and R. H. Müller, Electrophoresis 14, 1382 (1993).

61. T. Blunk, M. Lück, A. Calvör, D. F. Hochstrasser, J. C. Sanchez, B. W. Müller, and R. H. Müller, Eur. J. Pharm. Biopharm. 42, 262 (1996).

62. J. C. Leroux, P. Gravel, L. Balant, B. Volet, B. M. Anner, E. Allemann, E. Doelker, and R. Gurny, J. Biomed. Mater. Res. 28, 471

63. R. Gref, A. Domb, P. Quellec, T. Blunk, R. H. Müller, J. M. Verbavatz, and R. Langer, Adv. Drug Delivery Rev. 16, 215 (1995).

64. R. Gref, M. Lück, P. Quellec, M. Marchand, E. Dellacherie, S. Harnish, T. Blunk, and R. H. Müller, Colloids Surf., B 18, 301 (2000).

65. W. Gombotz, W. Guanghui, T. Horbett, and A. Hoffman, J. Biomed. Mater. Res. 25, 1547 (1991).

66. J. C. Leroux, F. De Jaeghere, B. Anner, E. Doelker, and R. Gurny, Life Sci. 57, 695 (1995).

67. F. De Jaeghere, E. Allemann, J. Feijen, T. Kissel, E. Doelker, and R. Gurny, J. Drug Target 8, 143 (2000).

68. V. Mosqueira, P. Legrand, R. Gref, B. Heurtault, M. Appel, and

69. S. Dunn, A. Coombes, M. C. Garnett, S. S. Davis, M. C. Davies, and L. Illum, J. Controlled Release 44, 65 (1997).

70. T. Gorner, R. Gref, D. Michenot, F. Sommer, M. Tran, and E. Dellacherie, J. Controlled Release 57, 259 (1999).

71. J. Matsumoto, Y. Nakada, K. Sakurai, T. Nakamura, and Y. Taka-hashi, Int. J. Pharm. 185, 93 (1999).

72. H. Redhead, S. S. Davis, and L. Illum, J. Controlled Release 70, 353 (2001).

73. T. Verrecchia, G. Spenlehauer, D. Bazile, A. Murry-Brelier, Y. Archimbaud, and M. Veillard, J. Controlled Release 36, 49

74. E. Allemann, N. Brasseur, O. Benrezzak, J. Rousseau, S. Kudrevich, R. Boyle, J. Leroux, R. Gurny, and J. Van Lier, J. Pharm. Pharmacol. 47, 382 (1995).

75. E. Allemann, J. Rousseau, N. Brasseur, S. Kudrevich, K. Lewis, and J. van Lier, Int. J. Cancer 66, 821 (1996).

76. C. Emile, D. Bazile, F. Herman, C. Helene, and M. Veillard, Drug Deliv. 3, 187 (1996).

77. C. Allen, D. Maysinger, and A. Eisenberg, Colloids Surf., B 16, 3 (1999).

78. H. Suh, B. Jeong, R. Rathi, and S. Kim, J. Biomed. Mater. Res. 42, 331 (1998).

79. H. S. Yoo and T. G. Park, J. Controlled Release 70, 63 (2001).

80. R. Gref, P. Quellec, A. Sanchez, P. Calvo, E . Dellacherie, and M. Alonso, Eur. J. Pharm. Biopharm. 51, 111 (2001).

81. J. Molina, J. Urbina, R. Gref, Z. Brener, and J. Rodrigues Jr., J. Antimicrob. Chemother. 47, 101 (2001).

82. T. Govender, T. Riley, T. Ehtezazi, M. C. Garnett, S. Stolnik, L. Illum, and S. S. Davis, Int. J. Pharm. 199, 95 (2000).

83. Y. Li, Y. Pei, Z. Zhou, X. Zhang, Z. Gu, J. Ding, J. Zhou, X. Gao, and J. Zhu, J. Controlled Release 71, 287 (2001).

84. Y. Li, Y. Pei, Z. Zhou, X. Zhang, Z. Gu, J. Ding, J. Zhou, X. Gao, and J. Zhu, Biol. Pharm. Bull. 24, 662 (2001).

85. G. Fontana, M. Licciardi, S. Mansueto, D. Schillaci, and G. Giammona, Biomaterials, 22, 2857 (2001).

86. I. Brigger, P. Chaminade, V. Marsaud, M. Appel, M. Besnard, R. Gurny, M. Renoir, and P. Couvreur, Int. J. Pharm. 214, 37 (2001).

87. I. G. Shin, S. Y. Kim , Y. M. Lee , C. S. Cho, and Y. K. Sung, J. Controlled Release 51, 1 (1998).

88. S. Kim, I. Shin, and Y. Lee, J. Controlled Release 56, 197 (1998).

89. S. Y. Kim, I. G. Shin, Y. M. Lee, C. S. Cho, and Y. K. Sung, J. Controlled Release 51, 13 (1998).

90. C. Allen, Y. Yu, D. Maysinger, and A. Eisenberg, Bioconjugate Chem. 9, 564 (1998).

91. C. Allen, Y. Yu, A. Eisenberg, and D. Maysinger, Biochim. Bio-phys. Acta 1421, 32 (1999).

92. C. Allen, A. Eisenberg, J. Mrsic, and D. Maysinger, Drug Deliv. 7, 139 (2000).

93. C. Emile, D. Bazile, F. Herman, C. Helene, and M. Veillard, Drug Delivery 3, 187 (1996).

94. C. Allen, J. Han, Y. Yu, D. Maysinger, and A. Eisenberg, J. Controlled Release 63, 275 (2000).

95. C. Emile, D. Bazile, F. Herman, C. Helene, and M. Veillard, Drug Delivery 3, 187 (1996).

96. M. C. Perez, A. Sanchez, D. Putnam, D. Ting, R. Langer, and M. Alonso, J. Controlled Release 75, 211 (2001).

97. P. Quellec, R. Gref, L. Perrin, E. Dellacherie, F. Sommer, J. Ver-bavatz, and M. Alonso, J. Biomed. Mater. Res. 42, 45 (1998).

98. P. Quellec, R. Gref, E. Dellacherie, F. Sommer, M. Tran, and M. Alonso, J. Biomed. Mater. Res. 47, 388 (1999).

99. M. Blanco and M. J. Alonso, Eur. J. Pharm. Biopharm. 43, 287 (1997).

100. Y. Li, Y. Pei, X. Zhang, Z. Gu, Z. Zhu, W. Yuan, J. Zhou, and X. Gao, J. Controlled Release 71, 203 (2001).

101. M. F. Zambaux, F. Bonneaux, R. Gref, E. Dellacherie, and C. Vigneron, Int. J. Pharm. 212, 1 (2001).

102. M. J. Alonso, B. Villamayor, M. Tobio, S. Schwendeman, R. K. Gupta, G. Siber, and R. Langer, Proceed. Intern. Symp. Rel. Bioact. Mater. 23, pp. 825-826 (1996).

103. M. Tobio, R. Gref, A. Sanchez, R. Langer, and M. J. Alonso, Pharm. Res. 15, 274 (1998).

104. M. Tobio, A. Sanchez, A. Vila, I. Soriano, C. Evora, J. Vila-Jato, and M. J. Alonso, Colloids Surf., B 18, 315 (2000).

105. J. P. Plard and D. Bazile, Colloids Surf., B 16, 173 (1999).

106. Z. Panagi, A. Beletsi, G. Evangelatos, E. Livaniou, D. S. Ithakissios, and K. Avgoustakis, Int. J. Pharm. 221, 143 (2001).

107. M. T. Peracchia, E. Fattal, D. Desmaele, M. Besnard, J. Noel, J. Gomis, M. Appel, J. D'Angelo, and P. Couvreur, J. Controlled Release 60, 121 (1999).

108. P. Calvo, B. Gouritin, H. Villarroya, F. Eclancher, C. Giannavola, C. Klein, J. P. Andreux, and P. Couvreur, Eur. J. Neurosci. 15, 1317 (2002).

109. I. Brigger, J. Morizet, G. Aubert, H. Chacun, M. J. Terrier-Lacombe, and P. Couvreur, J. Pharmacol. Exp. Ther. 303, 928 (2002).

110. P. Calvo, B. Gouritin, I. Brigger, C. Lasmezas, J. Deslys, A. Williams, J. P. Andreux, D. Dormont, and P. Couvreur, J. Neu-rosci. Meth. 111, 151 (2001).

111. R. Fernandez-Urussuno, E. Fattal, D. Porquet, J. Feger, and P. Couvreur, Toxicol. Appl. Pharmacol. 130, 272 (1995).

112. T. M. Allen, Adv. Drug Delivery Rev. 13, 185 (1994).

113. M. Woodle and D. Lassic, Biochim. Biophys. Acta 1113,171 (1992).

114. V. Torchilin and V. Trubetskoy, Adv. Drug Delivery Rev. 16, 141 (1995).

115. M. Woodle, C. Engberts, and S. Zalipsky, Bioconjugate Chem. 5, 493 (1994).

116. C. Chern, C. Lee, and Y. Tsai, Colloid Polym. Sci. 275, 841 (1997).

117. C. Passirani, L. Ferrarini, G. Barratt, J. P. Devissaguet, and D. Labarre, J. Biomat. Sci—Polym. E. 10, 47 (1999).

118. C. Passirani, G. Barratt, J. P. Devissaguet, and D. Labarre, Pharm. Res. 15, 1046 (1998).

119. C. Passirani, G. Barratt, J. P. Devissaguet, and D. Labarre, Life Sci. 62, 775 (1998).

120. N. Jaulin, M. Appel, C. Passirani, G. Barratt, and D. Labarre, J. Drug Target. 8, 165 (2000).

121. A. G. Coombes, S. Tasker, M. Lindblad, J. Holmgren, K. Hoste, V. Toncheva, E. Schacht, M. C. Davies, L. Illum, and S. S. Davis, Biomaterials 18, 1153 (1997).

122. C. Rouzes, R. Gref, M. Leonard, A. De Sousa Delgado, and E. Dellacherie, J. Biomed. Mater. Res. 50, 557 (2000).

123. R. Gref, J. Rodrigues, and P. Couvreur, Macromolecules 35, 9861 (2002).

124. R. Gref, C. Lemarchand, and P. Couvreur, "Proceed. 28th Int. Symp. Controll. Release Bioactive Materials," pp. 23-27. San Diego, 2001.

125. B. Stella, S. Arpicco, M. T. Peracchia, D. Desmaele, J. Hoebeke, M. Renoir, J. D'Angelo, L. Cattel, and P. Couvreur, J. Pharm. Sci. 89, 1452 (2000).

126. R. Gref, E. Mysiakine, G. Barratt, and P. Couvreur, Biomaterials 24, 4529 (2003).

Encyclopedia of Nanoscience and Nanotechnology

www.aspbs.com/enn

0 0

Post a comment